 |
This Is MS Multiple Sclerosis Community: Knowledge & SupportWelcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones. |
| It is currently Sun May 19, 2013 3:24 pm |
|
All times are UTC - 8 hours [ DST ] |
 
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| Rici |
|
|||||
Joined: Thu Nov 12, 2009 4:00 pm Posts: 282 Location: Poland Bialystok |
|
|||||
| Top |  |
|||||
 |
||||||
|
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
 | Novartis says FTY720 trial continues despite death | 1 | 2008 | Sat Jul 05, 2008 6:15 am | |
| "Side effects : death" | 6 | 879 | Sat May 18, 2013 7:54 am | |
| Phase-III Laquinimod trial completed patient enrollment | 0 | 1152 | Tue Nov 18, 2008 7:46 am | |
| Tysabri | 3 | 1504 | Thu Oct 27, 2005 7:18 am | |
| Two years of Tysabri | 8 | 2184 | Tue Jul 22, 2008 6:08 pm | |
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |
Login
Register
FAQ
Search
